Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum.
Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum.
复制标题
DOI:
10.1016/j.jtho.2018.05.014
复制
发表时间:
2018-08
期刊:
影响因子:
--
通讯作者:
Ostroff JS
中科院分区:
文献类型:
--
作者:
Hamann HA;Ver Hoeve ES;Carter-Harris L;Studts JL;Ostroff JS
The public health imperative to reduce the burden of lung cancer has seen unprecedented progress in recent years. Realizing fully the advances in lung cancer treatment and control requires attention to potential barriers in their momentum and implementation. In this analysis, we present and evaluate the argument that stigma is a highly significant barrier to fulfilling the clinical promise of advanced care and reduced lung cancer burden. This evaluation of lung cancer stigma is based on a multilevel perspective that incorporates the individual, persons in their immediate environment, the healthcare system, and the larger societal structure which shapes perceptions and decisions. We also consider current interventions and interventional needs within and across aspects of the lung cancer continuum, including prevention, screening, diagnosis, treatment, and survivorship. Current evidence suggests that stigma detrimentally impacts psychosocial, communication, and behavioral outcomes over the entire lung cancer control continuum and across multiple levels. Interventional efforts to alleviate stigma in the context of lung cancer show promise, yet more work is needed to evaluate their impact. Understanding and addressing the multi-level role of stigma is a crucial area for future study in order to realize the full benefits offered by lung cancer prevention, control, and treatment. Coordinated, interdisciplinary, and well-conceptualized efforts have the potential to reduce the barrier of stigma in the context of lung cancer and facilitate demonstrable improvements in clinical care and quality of life.
登录
查看更多内容
影响因子:
5.4
作者:
Corner, J;Hopkinson, J;Roffe, L
通讯作者:
Roffe, L
DOI:
10.1002/2327-6924.12227
发表时间:
2015-05-01
影响因子:
1.2
作者:
Carter-Harris, Lisa
通讯作者:
Carter-Harris, Lisa
影响因子:
4.5
作者:
Carter, Ashley J. R.;Nguyen, Cecine N.
通讯作者:
Nguyen, Cecine N.
影响因子:
12.7
作者:
Bayer, R;Stuber, J
通讯作者:
Stuber, J
DOI:
10.1016/j.jtho.2016.11.2221
发表时间:
2017-03
期刊:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
影响因子:
--
作者:
David EA;Daly ME;Li CS;Chiu CL;Cooke DT;Brown LM;Melnikow J;Kelly K;Canter RJ
通讯作者:
Canter RJ